Myriad Genetics, Inc. · NASDAQ:MYGN
Donnelly Brian J received 5,000 Myriad Genetics, Inc. shares as an award (Form 4)
Traded Jun 11, 2026 · Filed Jun 12, 2026
On Jun 11, 2026, Donnelly Brian J (Chief Commerical Officer) received 5,000 Myriad Genetics, Inc. shares as an award at US$3.94 for US$19,700, leaving 573,363 shares. Filed Jun 12, 2026 (Form 4).
- Awarded
- 5,000 shares
- Price
- US$3.94
- Value
- US$19,700
- Holding after
- 573,363 shares
- Trading plan
- No
- Role
- Chief Commerical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock | Award | 5,000 | US$3.94 | 573,363 | Direct |
Source
Related
- Myriad Genetics, Inc.
- Donnelly Brian J
- Myriad Genetics, Inc. shareholders
- Form 4 · Donnelly Brian J · May 4, 2026
- Form 4 · Wheeler Benjamin Richard · Sep 22, 2026
- Form 4 · Sikri Vishal · Sep 17, 2026
- Form 4 · Fox Jennifer Lynne · Sep 8, 2026
- Schedule 13G · BlackRock Portfolio Management LLC · Sep 4, 2026
- Form 4 · Wheeler Benjamin Richard · Aug 17, 2026